Medtronic (MDT) Cash from Operations Growth (3y) (2017 - 2026)
Medtronic (MDT) Cash from Operations Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.83% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 5.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 20.35% |
| Oct 24, 2025 | 0.11% |
| Jul 25, 2025 | 0.15% |
| Apr 25, 2025 | 7.11% |
| Jan 24, 2025 | 4.90% |
| Oct 25, 2024 | -18.49% |
| Jul 26, 2024 | -8.62% |
| Apr 26, 2024 | 16.75% |
| Jan 26, 2024 | 1.64% |
| Oct 27, 2023 | -29.18% |
| Jul 28, 2023 | 46.55% |
| Apr 28, 2023 | 19.27% |
| Jan 27, 2023 | -13.20% |
| Oct 28, 2022 | -20.96% |
| Jul 29, 2022 | -10.49% |
| Apr 29, 2022 | -0.48% |
| Jan 28, 2022 | 2.73% |
| Oct 29, 2021 | 15.00% |
| Jul 30, 2021 | -8.78% |
| Apr 30, 2021 | 18.90% |